National Vaccine Advisory Committee (NVAC)
Established in 1987, the National Vaccine Advisory Committee (NVAC) recommends ways to achieve optimal prevention of human infectious diseases through vaccine development, and provides direction to prevent adverse reactions to vaccines. This advice is presented to the Assistant Secretary for Health who serves as the Director of National Vaccine Program on matters related to program responsibilities.
Public Comment Now Open!
On behalf of the National Vaccine Advisory Committee (NVAC), the National Vaccine Program Office is soliciting public comment on the draft report and draft recommendations on strengthening the effectiveness of national, state, and local efforts to improve HPV vaccination coverage in the United States. To view the report, click here. Comments for consideration by the NVAC should be sent to email@example.com and received no later than 5:00 p.m., Eastern Time on Friday, June 15, 2018.
A link to the official Federal Register Notice will be posted the week of May 28.
Functions of NVAC
- Studies and recommends ways to encourage the availability of an adequate supply of safe and effective vaccination products in the States.
- Recommends research priorities and other measures the Director of the National Vaccine Program should take to enhance the safety and efficacy of vaccines.
- Advises the Director of the Program in implementation of sections 2102 and 2103 of the Public Health Service Act.
- Identifies the most important areas of government and non-government cooperation that should be considered in implementing sections 2102 and 2103 of the Public Health Service Act.